Texas Oncology-Paris — Paris, Texas

Texas Oncology-Paris is a clinical research site located in Paris, Texas, United States 75460.

Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.

Texas Oncology-Paris has participated in 15 clinical trials with 3 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer.

Sponsors: Pfizer, Gilead Sciences, Merrimack Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Paris

Browse all research sites in Texas · View every site in Paris

• Paris Regional Cancer Center
• Research Site
• Texas Oncology-Northeast Texas
• Texas Oncology - P.A.- Paris
• Texas Oncology
• Pfizer Investigational Site
• Tapia Internal Medicine Clinic
• Clinical Trial Site
• Local Institution - 017-878-C
• Paris Cancer Center (PCC), Texas Oncology
• Texas Oncology PA - Paris

Sponsor Feasibility Report

Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Paris?

Texas Oncology-Paris has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Paris conducted?

Texas Oncology-Paris has 15 clinical trials on record, with 3 currently active. Their work covers Non-small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer.

Is Texas Oncology-Paris accredited by Crixeo Clinical Trials?

Texas Oncology-Paris has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Texas Oncology-Paris?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.